JP Morgan Chase
NBP

JP Morgan Chase’s NovaBridge Biosciences American Depositary Shares NBP Stock Holding History

JP Morgan Chase’s Portfolio NBP Stock Details NBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$161K Buy
81,556
+24,067
+42% +$49.1K ﹤0.01% 5736
2026
Q1 		$129K Sell
57,489
-74,341
-56% -$249K ﹤0.01% 5699
2025
Q4 		$525K Sell
131,830
-18,334
-12% -$81.1K ﹤0.01% 4988
2025
Q3 		$568K Buy
+150,164
New +$510K ﹤0.01% 4942
2025
Q2 		– Sell
-5,000
Closed -$4.12K – 7360
2025
Q1 		$4.12K Buy
+5,000
New +$4.75K ﹤0.01% 6454
2023
Q4 		– Sell
-477,895
Closed -$631K – 7681
2023
Q3 		$631K Sell
477,895
-119,479
-20% -$262K ﹤0.01% 4349
2023
Q2 		$1.79M Buy
597,374
+37,079
+7% +$119K ﹤0.01% 3618
2023
Q1 		$1.94M Sell
560,295
-217,250
-28% -$1.05M ﹤0.01% 3565
2022
Q4 		$3.25M Buy
777,545
+771,682
+13,162% +$2.92M ﹤0.01% 3180
2022
Q3 		$24K Sell
5,863
-243,109
-98% -$1.84M ﹤0.01% 5756
2022
Q2 		$2.81M Buy
248,972
+132,835
+114% +$1.59M ﹤0.01% 3277
2022
Q1 		$1.89M Buy
116,137
+113,787
+4,842% +$2.92M ﹤0.01% 3805
2021
Q4 		$111K Sell
2,350
-23,940
-91% -$1.44M ﹤0.01% 5629
2021
Q3 		$1.91M Sell
26,290
-124,008
-83% -$8.97M ﹤0.01% 3836
2021
Q2 		$12.6M Buy
150,298
+7,075
+5% +$467K ﹤0.01% 2231
2021
Q1 		$6.94M Buy
143,223
+143,211
+1,193,425% +$7.77M ﹤0.01% 2696
2020
Q4 		$1K Sell
12
-6,049
-100% -$238K ﹤0.01% 5550
2020
Q3 		$233K Buy
6,061
+5,914
+4,023% +$195K ﹤0.01% 4288
2020
Q2 		$4K Buy
+147
New +$3.04K ﹤0.01% 5202

Other funds holding NBP

HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
ACM
AIHC Capital Management Central $104M AUM
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $22.2B AUM 58.34% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

JP Morgan Chase's NBP Position: Q2 2026 in Review

JP Morgan Chase increased its NovaBridge Biosciences American Depositary Shares (NBP) stake by 42% in Q2 2026, buying an estimated $49.1K and bringing the position to 81,556 shares worth $161K. The position accounts for ﹤0.01% of the portfolio, ranked #5736.

JP Morgan Chase first reported a position in NBP in Q2 2020 and has held it in 19 quarters since. The position peaked at $12.6M in Q2 2021. 49 funds tracked by Wall St. Rank hold NBP as of Q2 2026.

  • JP Morgan Chase held 81,556 shares of NovaBridge Biosciences American Depositary Shares worth $161K as of Q2 2026.
  • JP Morgan Chase bought 24,067 NovaBridge Biosciences American Depositary Shares shares in Q2 2026, an estimated $49.1K.
  • NovaBridge Biosciences American Depositary Shares made up ﹤0.01% of JP Morgan Chase's portfolio in Q2 2026, its #5736 holding.
  • JP Morgan Chase first reported a position in NovaBridge Biosciences American Depositary Shares in Q2 2020 and has held it in 19 quarters since.
  • JP Morgan Chase's NovaBridge Biosciences American Depositary Shares position peaked at $12.6M in Q2 2021.
  • 49 funds tracked by Wall St. Rank held NovaBridge Biosciences American Depositary Shares as of Q2 2026.

Based on JP Morgan Chase's 13F filing for Q2 2026, filed 12 Aug 2026.